Patsy Clark

1.0k total citations
17 papers, 841 citations indexed

About

Patsy Clark is a scholar working on Pharmacology, Genetics and Cancer Research. According to data from OpenAlex, Patsy Clark has authored 17 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 6 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Patsy Clark's work include Inflammatory mediators and NSAID effects (13 papers), Estrogen and related hormone effects (6 papers) and Synthesis of β-Lactam Compounds (3 papers). Patsy Clark is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Estrogen and related hormone effects (6 papers) and Synthesis of β-Lactam Compounds (3 papers). Patsy Clark collaborates with scholars based in Canada, United States and New Zealand. Patsy Clark's co-authors include Daigen Xu, Laurent Audoly, Marie‐Claude Mathieu, Denis Riendeau, Glenn S. Belinsky, Masako Nakanishi, Kevin P. Claffey, David C. Montrose, Daniel W. Rosenberg and Prashant R. Nambiar and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of the American Society of Nephrology.

In The Last Decade

Patsy Clark

17 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patsy Clark Canada 15 482 245 199 127 117 17 841
Lutz Bräutigam Germany 10 553 1.1× 283 1.2× 206 1.0× 95 0.7× 148 1.3× 12 954
James D. Eskra United States 17 358 0.7× 206 0.8× 97 0.5× 119 0.9× 81 0.7× 30 921
Marie‐Claude Carrière Canada 13 407 0.8× 275 1.1× 143 0.7× 135 1.1× 215 1.8× 14 927
E Fosslien United States 7 302 0.6× 203 0.8× 132 0.7× 75 0.6× 55 0.5× 11 682
Russell D. Klein United States 20 305 0.6× 524 2.1× 290 1.5× 138 1.1× 43 0.4× 24 1.1k
Kimberly O. Cameron United States 16 200 0.4× 269 1.1× 211 1.1× 57 0.4× 271 2.3× 20 932
Sung Hyeok Hong United States 10 218 0.5× 324 1.3× 131 0.7× 91 0.7× 48 0.4× 17 860
J.E. Tateson United Kingdom 11 379 0.8× 339 1.4× 96 0.5× 163 1.3× 142 1.2× 17 1.1k
Angela M. Acquaviva Italy 19 294 0.6× 427 1.7× 177 0.9× 60 0.5× 34 0.3× 33 1.1k
Yoshiharu Kikawa Japan 15 182 0.4× 555 2.3× 110 0.6× 125 1.0× 41 0.4× 51 1.1k

Countries citing papers authored by Patsy Clark

Since Specialization
Citations

This map shows the geographic impact of Patsy Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patsy Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patsy Clark more than expected).

Fields of papers citing papers by Patsy Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patsy Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patsy Clark. The network helps show where Patsy Clark may publish in the future.

Co-authorship network of co-authors of Patsy Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Patsy Clark. A scholar is included among the top collaborators of Patsy Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patsy Clark. Patsy Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Burch, Jason D., John Colucci, Claudio F. Sturino, et al.. (2010). Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 21(3). 1041–1046. 12 indexed citations
2.
Boyd, Michael J., Carl Berthelette, Patsy Clark, et al.. (2010). A novel series of potent and selective EP4 receptor ligands: Facile modulation of agonism and antagonism. Bioorganic & Medicinal Chemistry Letters. 21(1). 484–487. 18 indexed citations
3.
Blouin, Marc, Yongxin Han, Jason D. Burch, et al.. (2010). The Discovery of 4-{1-[({2,5-Dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic Acid (MK-2894), A Potent and Selective Prostaglandin E2Subtype 4 Receptor Antagonist. Journal of Medicinal Chemistry. 53(5). 2227–2238. 29 indexed citations
4.
Jania, Leigh A., Subhashini Chandrasekharan, Michael G. Backlund, et al.. (2008). Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins & Other Lipid Mediators. 88(3-4). 73–81. 68 indexed citations
5.
Chen, Mei, Éric Boilard, Peter A. Nigrović, et al.. (2008). Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody‐driven K/BxN serum–transfer arthritis. Arthritis & Rheumatism. 58(5). 1354–1365. 62 indexed citations
6.
7.
Mathieu, Marie‐Claude, Simon Lord‐Dufour, Virginie Bernier, et al.. (2008). Mutual antagonistic relationship between prostaglandin E2 and IFN‐γ: Implications for rheumatoid arthritis. European Journal of Immunology. 38(7). 1900–1912. 20 indexed citations
8.
Burch, Jason D., Michel Belley, Réjean Fortin, et al.. (2008). Structure–activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 18(6). 2048–2054. 15 indexed citations
9.
Xu, Daigen, Patsy Clark, André Giroux, et al.. (2008). MF63 [2-(6-Chloro-1 H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a Selective Microsomal Prostaglandin E Synthase-1 Inhibitor, Relieves Pyresis and Pain in Preclinical Models of Inflammation. Journal of Pharmacology and Experimental Therapeutics. 326(3). 754–763. 129 indexed citations
10.
Nakanishi, Masako, David C. Montrose, Patsy Clark, et al.. (2008). Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis. Cancer Research. 68(9). 3251–3259. 142 indexed citations
11.
Clark, Patsy, Robert J. Gordon, Jocelyne Guay, et al.. (2007). Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species. European Journal of Pharmacology. 560(2-3). 216–224. 12 indexed citations
12.
Pulichino, Anne-Marie, Steve Rowland, Tom Wu, et al.. (2006). Prostacyclin Antagonism Reduces Pain and Inflammation in Rodent Models of Hyperalgesia and Chronic Arthritis. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1043–1050. 94 indexed citations
13.
Kapron, James T., Jin Wu, Timo Mauriala, et al.. (2006). Simultaneous analysis of prostanoids using liquid chromatography/high‐field asymmetric waveform ion mobility spectrometry/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 20(10). 1504–1510. 42 indexed citations
14.
Chandrasekharan, Subhashini, N.A. Foley, Leigh A. Jania, et al.. (2005). Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland. Journal of Lipid Research. 46(12). 2636–2648. 23 indexed citations
15.
Clark, Patsy, Alison Dziarmaga, Michael R. Eccles, & Paul Goodyer. (2004). Rescue of Defective Branching Nephrogenesis in Renal-Coloboma Syndrome by the Caspase Inhibitor, Z-VAD-fmk. Journal of the American Society of Nephrology. 15(2). 299–305. 35 indexed citations
16.
Dziarmaga, Alison, Patsy Clark, Cherie Stayner, et al.. (2003). Ureteric Bud Apoptosis and Renal Hypoplasia in Transgenic PAX2-Bax Fetal Mice Mimics the Renal-Coloboma Syndrome. Journal of the American Society of Nephrology. 14(11). 2767–2774. 40 indexed citations
17.
Burrows, Nigel, G. Terenghi, Patsy Clark, et al.. (1994). Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis.. Journal of Clinical Pathology. 47(10). 939–944. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lutz Bräutigam Breakdown of academic impact, for papers by James D. Eskra Breakdown of academic impact, for papers by Marie‐Claude Carrière Breakdown of academic impact, for papers by E Fosslien Breakdown of academic impact, for papers by Russell D. Klein Breakdown of academic impact, for papers by Kimberly O. Cameron Breakdown of academic impact, for papers by Sung Hyeok Hong Breakdown of academic impact, for papers by J.E. Tateson Breakdown of academic impact, for papers by Angela M. Acquaviva Breakdown of academic impact, for papers by Yoshiharu Kikawa
Rankless by CCL
2026